Most pharmaceutical informatics departments are unwilling to entrust any of their software development duties to an outside party, making the high-end tools developed by expert bioinformaticists unavailable to their bench biologists. But Sergey Ilyin, bioinformatics group leader at Johnson & Johnson Pharmaceutical Research & Development, said that a little flexibility allowed J&J’s bioinformaticists and biostatisticians to successfully collaborate with Spotfire, and to develop code that researchers across the organization were actually able to use.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.